-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Aquestive Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q2 2024.
- Aquestive Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $20M, a 14.9% increase year-over-year.
- Aquestive Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $73.6M, a 1.8% decline year-over-year.
- Aquestive Therapeutics, Inc. annual Costs and Expenses for 2023 was $65.7M, a 26.8% decline from 2022.
- Aquestive Therapeutics, Inc. annual Costs and Expenses for 2022 was $89.7M.
- Aquestive Therapeutics, Inc. annual Costs and Expenses for 2020 was $88.7M, a 15.7% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)